Antisense Oligonucleotide Therapeutics Market by Target Indication
Since the approval of Vitravene? (for the treatment of cytomegalovirus retinitis) in 1998, antisense oligonucleotide (ASO) therapies have evolved into a prominent class of therapeutics. In addition to the seven drugs, based on such molecules, that are commercially available, around 160 candidates are under development
Related Bookmarks
- Get the Best Medical Marijuana Card Online
- X-Ray Irradiators Market Research Reports, Size, Analysis, Trends and Forecast
- mRNA Therapeutics and Vaccines Market, 2020-2030
- Single-Use Bioreactors Market (2nd Edition) by Type of Reactor
- X Ray Irradiators Market Global Trends, Market Share, Industry Size, Growth and Opportunities
- Why Are Dental Implants An Option For You?
- Innovative Healthcare Solutions
- MRI Machine Claustrophobia
- MRI experience
- MRI for claustrophobic patients
Recent Profiles
Pk456 Tech
Office Manager
Kuailianth
Alberta Steam Xpress
Nhà Cái 88i
188esports
E2bet
888vnd
The 5280 Mermaid, Llc
789f Gamecom